GATA6 and colorectal carcinoma: Compared with the control, SNHG7 knockdown decreased the survival rate of ATB-resistant CRC cells treated with different concentrations of ATB, which was partially recovered by overexpressing GATA6 or adding miR-181a-5p inhibitor (Figure 5(a)).